Edition:
United Kingdom

IRLAB Therapeutics AB (IRLABa.ST)

IRLABa.ST on Stockholm Stock Exchange

340.00SEK
17 Jan 2019
Change (% chg)

-5.00kr (-1.45%)
Prev Close
345.00kr
Open
340.00kr
Day's High
350.00kr
Day's Low
336.00kr
Volume
3,065
Avg. Vol
6,383
52-wk High
388.00kr
52-wk Low
108.00kr

Chart for

About

IRLAB Therapeutics AB is a Sweden-based research and development company. It focuses on illnesses in the central nervous system and primarily on development of drugs to assist patients with Parkinson’s disease. The Company possesses a research platform Integrative Screening Process (ISP), which aims to discover and develop drug... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): kr1,032.33
Shares Outstanding(Mil.): 6.93
Dividend: --
Yield (%): --

Financials

  IRLABa.ST Industry Sector
P/E (TTM): -- 30.48 33.71
EPS (TTM): -8.46 -- --
ROI: -30.09 14.98 14.48
ROE: -30.13 16.31 15.99

Earnings vs. Estimates